Hypogonadism in men with type 2 diabetes: practical recommendations for diagnosis, treatment, and monitoring
Endokrynologia Polska · 19.11.2026
DOI: 10.5603/ep.113985 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endokrynologia Polska, online erschienen am 19.11.2026. Verfasst von Nadia Sawicka-Gutaj und 9 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Functional hypogonadism is a common complication of type 2 diabetes, particularly in patients with coexisting obesity or cardiometabolic complications. Nevertheless, this disorder often remains undiagnosed. This position statement provides practical recommendations for the diagnosis, treatment, and monitoring of hypogonadism in men with type 2 diabetes. In patients with type 2 diabetes who have symptoms suggestive of androgen deficiency, measurement of serum total testosterone is recommended. The diagnosis of hypogonadism requires the coexistence of clinical symptoms and a low testosterone concentration [total testosterone < 12 nmol/L (350 ng/dL) and/or calculated free testosterone (cfT) < 220 pmol/L (65 pg/mL)], confirmed by two measurements performed at least 4 weeks apart. The diagnosis of functional hypogonadism also requires exclusion of organic causes. Management should be based on a balanced diet, regular physical activity, pharmacotherapy aimed at achieving metabolic control of diabetes, and treatment of obesity. Testosterone therapy may be considered in symptomatic men who meet the biochemical criteria, primarily to improve quality of life, sexual function, body composition, and metabolic parameters. However, it should be regarded as adjunctive treatment supporting sustainable lifestyle change. Testosterone therapy may be initiated after contraindications, including current reproductive plans, have been excluded; regular monitoring is required. A targeted medical history, appropriate diagnosis of hypogonadism, lifestyle modification, careful selection of candidates for testosterone therapy, and adequate treatment monitoring may substantially improve care for men with type 2 diabetes and hypogonadism.
Zitieren
APA
Sawicka-Gutaj, N., Stańska, A., Rabijewski, M., Zozulińska-Ziółkiewicz, D., Kowalska, I., Zgliczyński, W., Kos-Kudła, B., Ruchała, M., Hubalewska-Dydejczyk, A., & Słowikowska-Hilczer, J. (2026). Hypogonadism in men with type 2 diabetes: practical recommendations for diagnosis, treatment, and monitoring. Endokrynologia Polska. https://doi.org/10.5603/ep.113985
Vancouver
Sawicka-Gutaj N, Stańska A, Rabijewski M, Zozulińska-Ziółkiewicz D, Kowalska I, Zgliczyński W, et al. Hypogonadism in men with type 2 diabetes: practical recommendations for diagnosis, treatment, and monitoring. Endokrynologia Polska. 2026. doi:10.5603/ep.113985
BibTeX
@article{SawickaGutaj2026,
author = {Sawicka-Gutaj, Nadia and Stańska, Alicja and Rabijewski, Michał and Zozulińska-Ziółkiewicz, Dorota and Kowalska, Irina and Zgliczyński, Wojciech and Kos-Kudła, Beata and Ruchała, Marek and Hubalewska-Dydejczyk, Alicja and Słowikowska-Hilczer, Jolanta},
title = {Hypogonadism in men with type 2 diabetes: practical recommendations for diagnosis, treatment, and monitoring},
journal = {Endokrynologia Polska},
year = {2026},
doi = {10.5603/ep.113985}
}
EUVIMED